• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤体积作为 T3 声门型喉癌患者生存预测因素的研究:一种新的患者选择方法。

Tumor volume as a predictor of survival in T3 glottic carcinoma: A novel approach to patient selection.

机构信息

Department of Otolaryngology, University of Florida, Gainesville, FL, USA; University of Florida Health Cancer Center, Gainesville, FL, USA.

Department of Otolaryngology, University of Florida, Gainesville, FL, USA.

出版信息

Oral Oncol. 2018 Apr;79:47-54. doi: 10.1016/j.oraloncology.2018.02.015. Epub 2018 Feb 22.

DOI:10.1016/j.oraloncology.2018.02.015
PMID:29598950
Abstract

BACKGROUND

The optimal treatment for T3 glottic cancers continues to be debated. Organ preservation has become the standard of care, but not all tumors respond equally. The purpose of this was to investigate the long-term survival outcomes of organ preservation protocols based on tumor volume.

METHODS

A retrospective review of prospectively collected data from 1966 to 2016 was performed. Patients with T3 vocal cord cancer treated with radiation therapy (RT) at the University of Florida were included. Local control rates as well as survival rates were determined with a Kaplan Meier and Cox regression analysis. Survival was analyzed as a function of tumor volume and an optimal cut point was determined.

RESULTS

107/234 patients were included. 79% received RT and 21% chemo-RT. 5-year local control was 61.5% and 5-year disease specific survival was 79.3%. Tumor volume was a significant predictor of survival (p = 0.007). An optimal cut point for tumor volume was 2.5 cc. Patients with tumor volumes ≥2.5 cc had significantly worse (p < 0.05) tumor control rates (100% vs. 70.4%).

CONCLUSION

Tumor volume is a significant predictor of survival outcomes in T3 vocal cord cancers, but will need external validation. Tumors <2.5 cc have favorable outcomes. Those with higher volume tumors should be counselled appropriately and be considered for primary surgical management.

摘要

背景

T3 声门型癌症的最佳治疗方法仍存在争议。保留器官已成为治疗标准,但并非所有肿瘤的反应都一样。本研究旨在探讨基于肿瘤体积的器官保留方案的长期生存结果。

方法

对 1966 年至 2016 年期间前瞻性收集的数据进行回顾性分析。纳入在佛罗里达大学接受放射治疗(RT)治疗的 T3 声带癌患者。采用 Kaplan-Meier 和 Cox 回归分析确定局部控制率和生存率。生存分析作为肿瘤体积的函数,并确定最佳截断点。

结果

共纳入 234 例患者中的 107 例。79%接受 RT,21%接受化疗-RT。5 年局部控制率为 61.5%,5 年疾病特异性生存率为 79.3%。肿瘤体积是生存的显著预测因素(p=0.007)。肿瘤体积的最佳截断点为 2.5cc。肿瘤体积≥2.5cc 的患者肿瘤控制率显著更差(p<0.05)(100% vs. 70.4%)。

结论

肿瘤体积是 T3 声带癌生存结果的重要预测因素,但需要外部验证。体积<2.5cc 的肿瘤预后良好。那些体积较大的肿瘤应适当告知,并考虑进行主要手术治疗。

相似文献

1
Tumor volume as a predictor of survival in T3 glottic carcinoma: A novel approach to patient selection.肿瘤体积作为 T3 声门型喉癌患者生存预测因素的研究:一种新的患者选择方法。
Oral Oncol. 2018 Apr;79:47-54. doi: 10.1016/j.oraloncology.2018.02.015. Epub 2018 Feb 22.
2
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗:治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.
3
Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.顺铂-氟尿嘧啶单纯化疗用于T1-T3N0声门鳞状细胞癌完全临床缓解者:五年结果
J Clin Oncol. 1996 Aug;14(8):2331-6. doi: 10.1200/JCO.1996.14.8.2331.
4
[Selection of surgical modalities for T3 glottic carcinoma].[T3 声门癌手术方式的选择]
Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):860-3.
5
A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.一项针对T2期声门癌的顺铂-氟尿嘧啶持续诱导化疗与环状软骨上部分喉切除术的临床试验。
Cancer. 1994 Nov 15;74(10):2781-90. doi: 10.1002/1097-0142(19941115)74:10<2781::aid-cncr2820741007>3.0.co;2-u.
6
Management of T3N0M0 glottic carcinoma: therapeutic outcomes.T3N0M0声门癌的治疗:治疗结果
Laryngoscope. 2002 Jul;112(7 Pt 1):1281-8. doi: 10.1097/00005537-200207000-00026.
7
Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.对仅接受放射治疗的声门型喉鳞状细胞癌T2N0M0患者的长期观察及挽救性手术
Acta Otolaryngol. 2012 May;132(5):546-51. doi: 10.3109/00016489.2011.646008. Epub 2012 Jan 21.
8
Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.经口激光显微手术作为特定T3期声门癌和声门上癌的主要治疗方法。
Head Neck. 2016 Jul;38(7):1107-12. doi: 10.1002/hed.24424. Epub 2016 Mar 11.
9
Primary surgical treatment of T3 glottic carcinoma: long-term results and decision-making aspects.T3 声门型喉癌的外科治疗:长期结果与决策分析。
Laryngoscope. 2012 Dec;122(12):2723-7. doi: 10.1002/lary.23580. Epub 2012 Sep 10.
10
Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.226例T3期喉癌患者经口激光显微手术治疗后的结果。
Head Neck. 2014 May;36(5):652-9. doi: 10.1002/hed.23338. Epub 2013 Jul 2.

引用本文的文献

1
Integrated comparative analysis of T-staging of laryngeal carcinoma on parallel versus non-parallel vocal cord CT planes with its potential treatment pitfalls.喉癌在声带平行与非平行CT平面上T分期的综合对比分析及其潜在治疗陷阱
PLoS One. 2025 Sep 2;20(9):e0330389. doi: 10.1371/journal.pone.0330389. eCollection 2025.
2
Superior loco-regional control after primary surgery compared to chemo-radiotherapy for advanced stage laryngeal cancer.与晚期喉癌的放化疗相比,初次手术后局部区域控制效果更佳。
Front Oncol. 2023 Aug 1;13:1132486. doi: 10.3389/fonc.2023.1132486. eCollection 2023.
3
Prognostic imaging variables for recurrent laryngeal and hypopharyngeal carcinoma treated with primary chemoradiotherapy: A systematic review and meta-analysis.
接受原发性放化疗的复发性喉癌和下咽癌的预后影像变量:一项系统评价和荟萃分析。
Head Neck. 2021 Jul;43(7):2202-2215. doi: 10.1002/hed.26698. Epub 2021 Apr 2.
4
[Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].[病理肿瘤体积预测局部晚期声门癌患者的生存结局]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Apr;35(4):316-320. doi: 10.13201/j.issn.2096-7993.2021.04.007.
5
Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma.原发性肿瘤体积作为鼻窦黏膜黑色素瘤患者远处转移和生存的预测指标。
Head Neck. 2020 Nov;42(11):3316-3325. doi: 10.1002/hed.26380. Epub 2020 Aug 1.